ABBV: 艾伯维

ABBV新闻

• 18:14 AbbVie Inc. (ABBV) Presents at EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities Transcript
• 15:30 AbbVie (ABBV) Up 3.5% Since Last Earnings Report: Can It Continue?
• 15:19 Atea Pharmaceuticals - I'm Optimistic Ahead Of Critical HPV Catalyst (NASDAQ:AVIR)
• 13:33 AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?
• 14:08 IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use
• 14:06 AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication
• 13:00 Building A $100,000 All-Weather Dividend Portfolio For May 2026 (NYSEARCA:SPY)
• 09:30 J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?
• 16:21 How Did AbbVie's Oncology Portfolio Perform in Q1 Despite Headwinds?
• 14:50 Dividend Income Update Q1 2026
• 12:43 Best Dividend Aristocrats: May 2026
• 03:25 My Dividend Stock Portfolio: New April Dividend Record - 100 Holdings With 5 Buys
• 06:53 Best Dividend Kings: May 2026
• 11:20 HDV: This May Not Be The ETF You Want, But It Could Be The One You Need Right Now
• 14:27 BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway
• 15:53 Apogee Therapeutics: Targeting Atopic Dermatitis (NASDAQ:APGE)
• 14:21 GSK Stock Declines 9% in a Month: Time to Buy, Hold or Exit?
• 15:17 J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth
• 13:00 Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
• 12:24 Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields -
• 16:20 Here's How Neuroscience Drugs Boost AbbVie's Q1 Sales Growth
• 16:38 Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?
• 15:46 ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
• 15:43 ANIP Valuation: Does 9.8x Forward P/E Offer Upside?